Related Experiment Videos
Simplified assay for antithrombin III activity using chromogenic peptide substrate. Manual and automated method
Scandinavian Journal of Haematology
|November 1, 1983
Summary
A simplified assay for antithrombin III (AT) is presented, offering rapid results and reliable quantification. This method correlates highly with existing techniques, confirming low AT levels in various clinical conditions.
Area of Science:
- Clinical Chemistry
- Hematology
- Biochemical Assays
Background:
- Accurate measurement of antithrombin III (AT) is crucial for diagnosing and managing thrombotic disorders.
- Existing manual assays for AT can be time-consuming and complex.
- Development of a simplified and rapid AT assay is needed for routine clinical practice.
Purpose of the Study:
- To describe a simplified and rapid method for the quantitative assay of antithrombin III (AT).
- To evaluate the performance of the new assay using different thrombin substrates and temperatures.
- To assess the correlation of the simplified assay with established methods and its utility in clinical settings.
Main Methods:
- A simplified assay for antithrombin III (AT) was developed using the thrombin substrate 2AcOH X H-D-CHG-Ala-Arg-pNA (Th-1) or H-D-Phe-Pip-Arg-pNA (S-2238).
- Assays were performed at 30°C or 37°C.
- The method was validated by comparing results with immunoquantification and an automated centrifugal analyzer (Cobas-Bio) in 80 patient plasma samples.
Main Results:
- The standard curve for the AT assay was linear across a broad range (12.5-150%).
- The simplified assay demonstrated high correlation (r = 0.96) with both immunoquantification and an automated method.
- The assay confirmed low AT levels in patients with hereditary deficiency, liver cirrhosis, disseminated intravascular coagulation (DIC), and during heparin treatment for thrombosis.
Conclusions:
- The described simplified AT assay is rapid, reliable, and suitable for routine clinical use.
- The assay's high correlation with existing methods validates its accuracy.
- This method effectively identifies patients with clinically significant low antithrombin III levels.